TEVA PHARMACEUTICAL INDUSTRIES LTD financial data

Symbol
TEVA on NYSE, TEVJF on OTC
Location
Tel Aviv
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 104 % +13.4%
Quick Ratio 27.64 % -7.8%
Debt-to-equity 512 % -1%
Return On Equity 11.07 %
Return On Assets 1.81 %
Operating Margin 10.89 % +2.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,147,282,512 shares +1.3%
Entity Public Float 18,320,000,000 USD +1.2%
Common Stock, Value, Issued 58,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 1,147,000,000 shares +1.2%
Weighted Average Number of Shares Outstanding, Diluted 1,164,000,000 shares +2.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 16,776,000,000 USD +0.02%
Selling and Marketing Expense 2,583,000,000 USD +3.3%
General and Administrative Expense 1,221,000,000 USD +6.2%
Operating Income (Loss) 1,827,000,000 USD +2.8%
Nonoperating Income (Expense) -932,000,000 USD +7.9%
Income Tax Expense (Benefit) 239,000,000 USD -65.2%
Net Income (Loss) Attributable to Parent 712,000,000 USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2,203,000,000 USD -33.6%
Accounts Receivable, after Allowance for Credit Loss, Current 3,810,000,000 USD +10.1%
Inventory, Net 3,323,000,000 USD -16.1%
Other Assets, Current 477,000,000 USD +7.2%
Assets, Current 12,736,000,000 USD +3.4%
Deferred Income Tax Assets, Net 1,634,000,000 USD -21.1%
Property, Plant and Equipment, Net 4,820,000,000 USD -15%
Operating Lease, Right-of-Use Asset 342,000,000 USD -6%
Goodwill 15,945,000,000 USD -1.1%
Other Assets, Noncurrent 444,000,000 USD -3.3%
Assets 39,856,000,000 USD -4.6%
Accounts Payable, Current 158,000,000 USD +46.3%
Employee-related Liabilities, Current 561,000,000 USD -9.4%
Liabilities, Current 11,491,000,000 USD -16.7%
Operating Lease, Liability, Noncurrent 283,000,000 USD -4.1%
Other Liabilities, Noncurrent 3,664,000,000 USD -15.7%
Liabilities 32,602,000,000 USD -7.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2,475,000,000 USD +10.6%
Retained Earnings (Accumulated Deficit) -14,243,000,000 USD +4.8%
Stockholders' Equity Attributable to Parent 7,250,000,000 USD +19.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 7,254,000,000 USD +13.6%
Liabilities and Equity 39,856,000,000 USD -4.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1,066,000,000 USD -42.6%
Net Cash Provided by (Used in) Financing Activities -2,865,000,000 USD -69.2%
Net Cash Provided by (Used in) Investing Activities 774,000,000 USD -13.1%
Common Stock, Shares Authorized 2,495,000,000 shares 0%
Common Stock, Shares, Issued 1,253,000,000 shares +1%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1,115,000,000 USD -2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2,203,000,000 USD -33.6%
Deferred Tax Assets, Valuation Allowance 2,017,000,000 USD -33%
Deferred Tax Assets, Gross 1,799,000,000 USD -0.72%
Operating Lease, Liability 383,000,000 USD -8.2%
Payments to Acquire Property, Plant, and Equipment 119,000,000 USD -6.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1,006,000,000 USD
Lessee, Operating Lease, Liability, to be Paid 495,000,000 USD -0.2%
Property, Plant and Equipment, Gross 8,991,000,000 USD -21%
Operating Lease, Liability, Current 296,000,000 USD -7.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 102,000,000 USD +4.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 120,000,000 USD +3.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +16.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 81,000,000 USD +1.2%
Unrecognized Tax Benefits 449,000,000 USD -31%
Lessee, Operating Lease, Liability, to be Paid, Year Four 57,000,000 USD -8.1%
Additional Paid in Capital 28,038,000,000 USD +0.64%
Amortization of Intangible Assets 581,000,000 USD -1.2%